deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02953301

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) (RESMAIN)

A Multicentre, Double Blind, Randomised, Placebo-controlled, Phase II Trial to Evaluate Resminostat for Maintenance Treatment of Patients With Advanced Stage (Stage IIB-IVB) Mycosis Fungoides (MF) or Sézary Syndrome (SS) That Have Achieved Disease Control With Systemic Therapy - the RESMAIN Study

Sponsor: 4SC AG

Conditions Lymphoma, T-Cell, Cutaneous Mycosis Fungoides Sezary Syndrome
Interventions Placebo resminostat
Updated 38 times since 2017 Last updated: Aug 29, 2024 Started: Nov 30, 2016 Primary completion: Mar 31, 2023 Completion: Aug 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02953301, this PHASE2 trial focuses on Lymphoma, T-Cell, Cutaneous and Mycosis Fungoides and remains completed. Sponsored by 4SC AG, it has been updated 38 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Apr 2017 · 31 days · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshot~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~May 2018 · 2 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshot~Feb 2020 – ~Jul 2020 · 5 months · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~Jun 2022 · 4 months · monthly snapshot~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~May 2023 · 4 months · monthly snapshot~May 2023 – ~Oct 2023 · 5 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

38 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. May 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE2

▶ Show 33 earlier versions

  1. Jan 2023 — May 2023 [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE2

  3. Jun 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  4. Feb 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  5. Oct 2021 — Feb 2022 [monthly]

    Recruiting PHASE2

  6. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  7. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  8. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE2

  9. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  10. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  11. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  12. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  13. Jul 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

  14. Feb 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  15. Aug 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  16. Feb 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  17. Jan 2019 — Feb 2019 [monthly]

    Recruiting PHASE2

  18. Dec 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  19. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  20. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  21. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE2

  22. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  23. Mar 2018 — May 2018 [monthly]

    Recruiting PHASE2

  24. Feb 2018 — Mar 2018 [monthly]

    Recruiting PHASE2

  25. Dec 2017 — Feb 2018 [monthly]

    Recruiting PHASE2

  26. Oct 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

  27. Aug 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

  28. Jul 2017 — Aug 2017 [monthly]

    Recruiting PHASE2

  29. Jun 2017 — Jul 2017 [monthly]

    Recruiting PHASE2

  30. Apr 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

  31. Mar 2017 — Apr 2017 [monthly]

    Recruiting PHASE2

  32. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE2

  33. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • 4SC AG
Data source: 4SC AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, Greece , Barcelona, Spain , Berlin, Germany , Birmingham, United Kingdom , Bochum, Germany , Bordeaux, France , Brussels, Belgium , Buxtehude, Germany , Clermont-Ferrand, France , Cologne, Germany and 43 more locations